2 citations
,
March 2024 in “Supportive Care in Cancer” In this study, manual cold capping was found to be effective in minimizing chemotherapy-induced alopecia, with 92.1% of patients retaining 50% or more of their hair, although effectiveness varied with different chemotherapy regimens.
2 citations
,
July 2023 in “JAAD Case Reports” This review discusses the potential role of a PADI3 gene variant in central centrifugal cicatricial alopecia among African-American women but reports no new clinical results.
2 citations
,
September 2022 in “Dermatologic therapy” This case series reports promising initial data on using microneedling with a dermaroller in trichotillomania patients, indicating potential efficacy in reducing compulsive hair-pulling behaviors and promoting hair regrowth.
2 citations
,
December 2021 in “International journal of Ayurveda and pharma research” This case report describes a 19-year-old girl with PCOS who experienced symptom improvement, including normalized menstruation, after two months of Ayurvedic treatment.
2 citations
,
February 2016 in “Düşünen Adam” This case report suggests that venlafaxine may cause hair loss in some patients, as demonstrated by a patient whose hair loss ceased after stopping the medication.
2 citations
,
November 2009 in “Korean journal of chemical engineering” This study found that the nonionic surfactant Brij 78 stabilized cationic minoxidil microparticles against aggregation, maintaining their substantivity in the presence of excess anionic surfactant.
2 citations
,
July 2008 in “Hair transplant forum international” This article highlights the increasing impact of methicillin-resistant Staphylococcus aureus as the most significant multi-drug-resistant organism affecting surgical settings, but reports no new experimental results.
1 citations
,
August 2024 in “World Journal of Advanced Pharmaceutical and Medical Research” This review discusses the causes, symptoms, and management of Polycystic Ovarian Syndrome (PCOS) without presenting new clinical results.
1 citations
,
July 2024 in “Clinical Case Reports” This case report documents an 8-year-old with tinea capitis, successfully treated with Terbinafine over 8 weeks, highlighting the importance of accurate diagnosis and timely intervention to prevent complications and recurrence.
1 citations
,
January 2024 in “Journal of the American Pharmacists Association” In this study of transgender and gender-diverse adults, the researchers observed that one-third of those on psychotropic medications within two years of starting hormone therapy experienced psychotropic polypharmacy, with a significantly higher likelihood of potential drug-hormone interactions in this group.
1 citations
,
November 2023 in “Journal of Innovations in Applied Pharmaceutical Science (JIAPS)” In this study, researchers developed a neem oil-based emulgel showcasing anti-dandruff properties with controlled dual release, observing formulation F5 providing a 65.27% release after 8 hours and the highest antifungal inhibition against Candida albicans.
1 citations
,
April 2023 in “Canadian journal of ophthalmology” This case report highlights the risk of retinal injuries from laser epilation, emphasizing the importance of practitioner training and protective eyewear to prevent irreversible vision damage.
1 citations
,
January 2023 in “Middle East Research Journal of Pharmaceutical Sciences” This review discusses the mechanisms and grading challenges of acne vulgaris, highlighting the need for better treatment strategies and reports no new experimental results.
1 citations
,
June 2022 in “Journal of Paediatrics and Child Health” This study observed that patients with paediatric-onset chronic hepatobiliary disease face a substantial health-care burden, highlighting challenges in transitioning this diverse group to adult care services.
1 citations
,
April 2022 in “Journal of Biological Regulators and Homeostatic Agents/Journal of Biological Regulators & Homeostatic Agents” This study reported that among 1337 patients receiving biocompatible artificial hair implants, common side effects included mild inflammation (7%) and itching (<3%), while patient satisfaction was high at 96%, though COVID-19 may have impacted some results.
1 citations
,
March 2022 in “F1000Research” This study found that many participants in India lacked awareness and proper practices for managing COVID-19 at home, highlighting the need for educational programs.
1 citations
,
December 2020 in “Media Keperawatan Politeknik Kesehatan Makassar” This study describes nursing care for a patient with Type 2 Diabetes, finding that nutritional management and insulin administration improved nutritional status and controlled blood glucose levels.
1 citations
,
October 2018 in “Journal of Mind and Medical Sciences” This study found that switching from brand name to generic drugs raises issues like patient and specialist information gaps, lack of collaboration between physicians and pharmacists, ineffective communication, and profit motives.
1 citations
,
October 2016 in “Iranian journal of psychiatry and behavioral sciences” This study presents two case reports where patients experienced hair loss during treatment with the SSRI sertraline, highlighting this rare but potential side effect.
1 citations
,
May 2015 in “Primary Health Care” This article discusses the classification of acne lesions and emphasizes the importance of evidence-based treatment and nursing care, without presenting new research results.
1 citations
,
October 2013 in “Urology” More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.
1 citations
,
August 2013 in “Journal of Clinical Epidemiology” This narrative review discusses various epidemiological study designs, the importance of reliable bias assessment tools, and the implications of database use for hypothesis testing in different research areas; it reports no new results.
1 citations
,
April 2008 in “Progrès en Urologie” Systematic end-of-trial biopsies are the most reliable way to assess outcomes.
1 citations
,
August 1978 in “Dicp-The annals of pharmacotherapy” A liquid protein diet caused hair loss in a young woman.
August 2026 in “Fabad Journal of Pharmaceutical Sciences” This study developed a Neusilin® US2-based solid self-nanoemulsifying drug delivery system for finasteride that showed improved stability and drug delivery, with complete dissolution comparable to standard Propecia® tablets.
July 2026 in “Dermatology Practical & Conceptual” In this study, the researchers observed that gastrointestinal side effects, such as flatulence and abdominal discomfort, were more common in patients taking low-dose oral minoxidil, especially among males and those using concurrent vasodilators.
July 2026 in “Journal of Investigative Dermatology” More research is needed to understand hair and scalp disorders in children with skin of color.
June 2026 in “Revista Ibero-Americana de Humanidades, Ciências e Educação” This study concluded that 5% topical Minoxidil remains a first-line treatment for female androgenetic alopecia by increasing hair density and thickness, while low-dose oral Minoxidil and combination therapies may also be effective.
June 2026 in “International Journal of Drug Delivery Technology” This study highlights the potential of polymeric micelles in enhancing the targeted delivery and efficacy of treatments for androgenetic alopecia, by offering improved retention on the scalp, extended release, and reduced systemic side effects compared to conventional therapies like minoxidil and finasteride.
June 2026 in “Expert Opinion on Pharmacotherapy” This article reviews emerging therapies for androgenetic alopecia, highlighting advances like androgen-receptor antagonists and improved minoxidil delivery that aim to enhance treatment efficacy and safety.